Evidence map›Paper›PMID 33066385›Full record

ArticleNutrients2020

Irene Andrés-Blasco, Sebastian Blesa, Ángela Vinué, Herminia González-Navarro, José Tomás Real, Sergio Martínez-Hervás, Julián Carretero, Antonio Ferrández-Izquierdo, Felipe Javier Chaves, Ana-Bárbara García-García

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Irene Andrés-BlascoGenomics and Diabetes Unit, Health Research Institute Clinic Hospital of Valencia-INCLIVA, Menendez Pelayo 4acc, 46010 Valencia, Spain.
Sebastian BlesaGenomics and Diabetes Unit, Health Research Institute Clinic Hospital of Valencia-INCLIVA, Menendez Pelayo 4acc, 46010 Valencia, Spain.
Ángela VinuéHealth Research Institute Clinic Hospital of Valencia-INCLIVA, 46010 Valencia, Spain.
Herminia González-NavarroHealth Research Institute Clinic Hospital of Valencia-INCLIVA, 46010 Valencia, Spain.
José Tomás RealHealth Research Institute Clinic Hospital of Valencia-INCLIVA, 46010 Valencia, Spain.
Sergio Martínez-HervásHealth Research Institute Clinic Hospital of Valencia-INCLIVA, 46010 Valencia, Spain.ORCID 0000-0002-6775-2034
Julián CarreteroDepartment of Physiology, University of Valencia, 46010 Valencia, Spain.
Antonio Ferrández-IzquierdoHealth Research Institute Clinic Hospital of Valencia-INCLIVA, 46010 Valencia, Spain.
Felipe Javier ChavesGenomics and Diabetes Unit, Health Research Institute Clinic Hospital of Valencia-INCLIVA, Menendez Pelayo 4acc, 46010 Valencia, Spain.
Ana-Bárbara García-GarcíaGenomics and Diabetes Unit, Health Research Institute Clinic Hospital of Valencia-INCLIVA, Menendez Pelayo 4acc, 46010 Valencia, Spain.ORCID 0000-0002-2162-6606
Universitat de València · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESMenéndez Pelayo International University · ESINCLIVA Health Research Institute · ES

Funding

Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas NAInstituto de Salud Carlos III FIS PI14/00874Instituto de Salud Carlos III PI17/00544
6 · The paper itself

Abstract

Macronutrients represent risk factors for hyperlipidemia or diabetes. Lipid alterations and type 2 diabetes mellitus are global health problems. Overexpression of sterol regulatory element-binding factor (

Indexed as

Blood GlucoseGene ExpressionAnimalsBody WeightCholesterolDiabetes Mellitus, Type 2Dietary SucroseDiet, High-FatFemaleInsulinLipid MetabolismMaleMice, Inbred C57BLMice, TransgenicSterol Regulatory Element Binding Protein 2Blood GlucoseCholesterolDietary SucroseInsulinSrebf2 protein, mouseSterol Regulatory Element Binding Protein 2atherosclerosiscarbohydrate metabolismcholesterolhigh-fathigh-sucrose dietlipid metabolismlipoproteinssterol regulatory element-binding protein 2 (SREBP-2)transgenic mice

Identifiers

PMID33066385
PMCPMC7602228
OpenAlexW3093035484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.